After watching this Matt Kaeberlein video here:
It made me think about the section where Matt and his guest debated about the optimal dosage of Rapamycin. Matt and his guest both agreed that Rapamycin is the best thing available right now as long as we can figure out the right dosage. The dosing arguments are as follows:
- Too low of a dose and Rapamycin does too little (minimal lifespan gain).
- Too high of a dose and Rapamycin has side effects such as hyperlipidemia, hyperglycemia, and even MTOR2 inhibition.
- Somewhere in between 1 and 2 is a dose that provides a maximum lifespan extension benefit.
Ok. We (mostly) all agree on this, so what can we do? Well, IMHO #1 is worse than #2, so, to me, that means we should err on the side of too much. Especially when we are young (55 yo and under). Why is that? Well, in the younger crowd, our bodies are healthier and we can handle the side effects of dyslipidemia and hyperglycemia better than someone older. Also, the ITP mouse studies have shown that the benefits of dosing in middle-aged mice extend throughout their lives even if Rapamycin is discontinued in old age. Therefore, this infers that there is a period where we can ālock inā the gains of high-dose Rapamycin and the gains become permanent even if dosing is discontinued. This is a factor that we often forget about. Fortunately, side effects are not ālocked inā and will disappear when dosing is lowered or stopped.
So, I would argue that we should all do a period of high-dose Rapamycin to ālock inā longevity benefits. However, we donāt want to go too high. What do we know about high dosages? Well, we (probably) donāt want to inhibit MTOR2.
From the research presented by @McAlister we know that MTOR rebound doesnāt occur at (bi)weekly levels of 20 mg equivalent or less and that at 40 mg, MTOR rebound is only experienced in 50% of people. So, letās set the ceiling at 20 mg every 2 weeks. Iād assume MTOR rebound is probably one of the best signs that your dosage is too high.
I would argue that if we took a dose of around 20 mg equivalence (6 mg + GFJ), for about 2-3 years every two weeks, we may be able to ālock inā a base level of benefit from Rapamycin for the rest of our lives and then we could reduce our dosage to a more ānormalā maintenance dosage of 6-14 mg equivalence (bi)weekly thereafter. However, we may have to deal with diarrhea and aphthous ulcers during high dose periods.
If we take high doses, we have to make sure that our lipids and blood glucose as well as other biomarkers donāt go out of range. However, if you pair Rapamycin with Metformin or Acarbose (glucose), Bempedoic Acid + Ezetimibe (lipids), and an SGLT2i (glucose), you should be able to mitigate the more serious side effects of Rapamycin.
I plan on changing my dosing to 6 mg + GFJ every two weeks. I am interested in what the rest of the community thinks about thisā¦